» Articles » PMID: 33232645

Three Decades of Bioelectrical Impedance Spectroscopy in Lymphedema Assessment: An Historical Perspective

Overview
Date 2020 Nov 24
PMID 33232645
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Bioelectrical impedance spectroscopy (BIS) is a technology that is widely used for the assessment of body composition. The method is based on the measurement of the electrical resistance of the body or a body region that can be quantitatively related to the amount of water in the tissues. Lymphedema is characterized, at least in its early stages, as an accumulation of lymph, an extracellular fluid. In the late 1980s, it was recognized that it might be possible to adapt BIS protocols to measure this increase in lymph volume. Subsequently, the use of BIS for the early detection of breast cancer-related lymphedema was demonstrated in the early 1990s, with BIS reference values indicative of lymphedema published in 2001. The subsequent two decades have seen BIS become a widely accepted method for lymphedema assessment. This review traces the evolution of the BIS technique since its inception and presents the current state of the art, with particular emphasis on utility in clinical practice.

Citing Articles

Biomarkers in lymphedema assessment: integrating elastography and muti-frequency bioimpedance analysis.

Jeon H, Kim D, Park S, Lee B, Kim D, Han H Biomark Med. 2024; 18(21-22):983-993.

PMID: 39445460 PMC: 11633427. DOI: 10.1080/17520363.2024.2415283.


Reliability of L-Dex Scores for Assessment of Unilateral Breast Cancer-Related Lymphedema.

Ward L, Gaitatzis K, Thompson B, Paramanandam V, Koelmeyer L Eur J Breast Health. 2024; 20(4):251-257.

PMID: 39323290 PMC: 11589188. DOI: 10.4274/ejbh.galenos.2024.2024-5-7.


Preoperative inter-arm differences and normative-based thresholds for lymphedema in Chinese breast cancer patients: Insights from a large cohort study.

Shen A, Li X, Zhao H, Ye J, Zhao H, Zhou Y Asia Pac J Oncol Nurs. 2024; 11(10):100567.

PMID: 39286531 PMC: 11403264. DOI: 10.1016/j.apjon.2024.100567.


Managing Lymphedema Induced by Lymphatic Filariasis: Implementing and Improving Care at the Individual and Programmatic Levels.

Mackenzie C, Kapa D, Krishnasastry S, Douglass J, Hoerauf A, Ottesen E Am J Trop Med Hyg. 2024; 111(4_Suppl):3-21.

PMID: 39084208 PMC: 11448485. DOI: 10.4269/ajtmh.23-0905.


Comparison of Volume Measurements and Bioimpedance Spectroscopy Using A Stand-on Device for Assessment of Unilateral Breast Cancer-Related Lymphedema.

Ward L, Thompson B, Gaitatzis K, Koelmeyer L Eur J Breast Health. 2024; 20(2):141-148.

PMID: 38571690 PMC: 10985575. DOI: 10.4274/ejbh.galenos.2024.2023-12-8.